Literature DB >> 18461366

Suppression of FasL expression in tumor cells and preventing TNF-induced apoptosis was better for immune cells survival.

Gaosi Xu1, Jiangguo Zhang.   

Abstract

OBJECTIVE: To elucidate if Fas/FasL signal pathway participates in the immune escape of tumor cells, and if contemporarily preventing Fas/FasL and TNF-induced apoptosis is better for immune cells survival than just blocking Fas/FasL-induced apoptotic signal.
METHODS: Suppression of FasL expression in mouse H22 hepatocellular cancer cells by siRNA technique. Wild-type Ad5 14.7K gene was amplified by PCR and transduced into Jurkat T cells. Detecting apoptosis of target Jurkat cells by Flow Cytometry. Detection of TNF-alpha in the culture supernatant of H22 cells by ELISA. FasL and 14.7K gene expression in stably transfected or transduced clones were determined by western blotting.
RESULTS: FasL expression in H22 cells was down-regulated following stable transfection with a plasmid encoding antisense FasL cDNA. Down-regulation of FasL expression in H22 cells had no effect on tumor growth in vitro. There was an apparent decrease in the number of apoptotic Jurkat T cells following coculture with transfected H22 cells, relative to coculture with FasL-expressing untransfected cells. Compared with untransduced Jurkat cells, apoptotic rates in 14.7K transduced Jurkat cells were significantly reduced in three different E/T ratios (P < 0.01), respectively.
CONCLUSIONS: Fas/FasL signal pathway participated in the immune escape of tumor cells by inducing immune cells apoptosis. Reducing the expression of FasL in tumor cells can decrease the apoptotic rate of immune cells. Further blocking of apoptotic signal pathway of immune cells by preventing TNF-induced apoptosis can increase the survival of immune cells.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18461366     DOI: 10.1007/s00432-008-0393-3

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  32 in total

Review 1.  Immune evasion by adenoviruses.

Authors:  J A Mahr; L R Gooding
Journal:  Immunol Rev       Date:  1999-04       Impact factor: 12.988

Review 2.  Cytokines that regulate autoimmune responses.

Authors:  M Falcone; N Sarvetnick
Journal:  Curr Opin Immunol       Date:  1999-12       Impact factor: 7.486

Review 3.  Immune evasion by adenovirus E3 proteins: exploitation of intracellular trafficking pathways.

Authors:  M Windheim; A Hilgendorf; H G Burgert
Journal:  Curr Top Microbiol Immunol       Date:  2004       Impact factor: 4.291

4.  A 14,700 MW protein from the E3 region of adenovirus inhibits cytolysis by tumor necrosis factor.

Authors:  L R Gooding; L W Elmore; A E Tollefson; H A Brady; W S Wold
Journal:  Cell       Date:  1988-05-06       Impact factor: 41.582

5.  The adenovirus E3-14.7K protein is a general inhibitor of tumor necrosis factor-mediated cytolysis.

Authors:  L R Gooding; I O Sofola; A E Tollefson; P Duerksen-Hughes; W S Wold
Journal:  J Immunol       Date:  1990-11-01       Impact factor: 5.422

6.  Role of Fas ligand expression in promoting escape from immune rejection in a spontaneous tumor model.

Authors:  D Céfai; L Favre; E Wattendorf; A Marti; R Jaggi; C D Gimmi
Journal:  Int J Cancer       Date:  2001-02-15       Impact factor: 7.396

7.  Depletion of the natural killer cell population in the peritoneum by AK-5 tumor cells overexpressing fas-ligand: a mechanism of immune evasion.

Authors:  A Khar; C Varalakshmi; B V Pardhasaradhi; A Mubarak Ali; A L Kumari
Journal:  Cell Immunol       Date:  1998-11-01       Impact factor: 4.868

Review 8.  Escape from immunotherapy: possible mechanisms that influence tumor regression/progression.

Authors:  Murrium Ahmad; Robert C Rees; Selman A Ali
Journal:  Cancer Immunol Immunother       Date:  2004-06-10       Impact factor: 6.968

9.  Adenovirus E3 14.7K protein functions in the absence of other adenovirus proteins to protect transfected cells from tumor necrosis factor cytolysis.

Authors:  T M Horton; T S Ranheim; L Aquino; D I Kusher; S K Saha; C F Ware; W S Wold; L R Gooding
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

10.  Monocyte-mediated tumoricidal activity via the tumor necrosis factor-related cytokine, TRAIL.

Authors:  T S Griffith; S R Wiley; M Z Kubin; L M Sedger; C R Maliszewski; N A Fanger
Journal:  J Exp Med       Date:  1999-04-19       Impact factor: 14.307

View more
  2 in total

1.  Efficiency of dendritic cell vaccination against B16 melanoma depends on the immunization route.

Authors:  Fanny Edele; Jan C Dudda; Eva Bachtanian; Thilo Jakob; Hanspeter Pircher; Stefan F Martin
Journal:  PLoS One       Date:  2014-08-14       Impact factor: 3.240

2.  TNF-α -308 A allele is associated with an increased risk of distant metastasis in rectal cancer patients from Southwestern China.

Authors:  Zhen Li; Shu-An Li; Ya Sun; Yu Liu; Wen-Liang Li; Li Yang; Yong Duan; Jingyu Li; Hao Guo; Tian-Ning Zou; Yunlong Li; Kun-Hua Wang
Journal:  PLoS One       Date:  2017-06-02       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.